Cargando…

Effectiveness of a Superelastic Nitinol Device for Fixation of Syndesmosis in Ankle Fracture

CATEGORY: Ankle; Trauma INTRODUCTION/PURPOSE: Syndesmosis injuries are increasingly common. Available fixation options are not yet optimal. The PUMA System (Panther Orthopedics, Sunnyvale, CA) is an FDA-cleared superelastic, nitinol-based fixation device for the ankle syndesmosis which provides stab...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellington, J. Kent, Hunt, Kenneth J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792651/
http://dx.doi.org/10.1177/2473011421S00187
_version_ 1784640420694720512
author Ellington, J. Kent
Hunt, Kenneth J.
author_facet Ellington, J. Kent
Hunt, Kenneth J.
author_sort Ellington, J. Kent
collection PubMed
description CATEGORY: Ankle; Trauma INTRODUCTION/PURPOSE: Syndesmosis injuries are increasingly common. Available fixation options are not yet optimal. The PUMA System (Panther Orthopedics, Sunnyvale, CA) is an FDA-cleared superelastic, nitinol-based fixation device for the ankle syndesmosis which provides stabilization without over-compression or loosening during cyclical loading. The spring-like design of the PUMA System allows physiological micro-motion while maintaining continuous compression and resisting syndesmosis widening, without material creep. The objective of this prospective study is to assess the effectiveness and complication rate of the PUMA device for treatment of fracture-associated syndesmosis injuries. METHODS: We prospectively collected radiographic and clinical data on 32 consecutive patients treated for fracture-associated syndesmotic disruption with the PUMA System(TM) at 8 centers. Primary outcome measures included adverse event rates, radiographic evaluations for syndesmosis integrity and implant failure, and rates of revision surgery. RESULTS: All 32 patients had successful repair of their ankle syndesmosis (Figure 1). The mean age of patients at time of operation was 42 years (range 16- 68). There were 13 females (13/32, 40.6%) and 19 (19/32, 59.4%) males. Postoperative radiographic evaluations confirmed satisfactory syndesmosis healing with maintained reduction in the ankle mortise in 33/33 (100%) ankles. There was no evidence of lysis, device migration or syndesmotic or medial clear space widening. There were no infections or soft tissue complications. All fractures healed. No devices required removal and there were no revision surgeries. CONCLUSION: The PUMA System(TM) provides physiologic stabilization of the syndesmosis due to the design features that allow for continuous compression without creep. We found no device-related complications nor construct failures in our series. The superelastic implant design allows physiologic motion at the syndesmosis but does not creep or stretch following displacement. This flexibility obviates the need for routine removal. The implant's low-profile buttons without suture and knot tying requirements eliminate the concern for subcutaneous knot irritation and slippage. Additional biomechanical and clinical outcomes study of this device may further optimize rehabilitation protocols for patients treated for syndesmotic injury.
format Online
Article
Text
id pubmed-8792651
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-87926512022-01-28 Effectiveness of a Superelastic Nitinol Device for Fixation of Syndesmosis in Ankle Fracture Ellington, J. Kent Hunt, Kenneth J. Foot Ankle Orthop Article CATEGORY: Ankle; Trauma INTRODUCTION/PURPOSE: Syndesmosis injuries are increasingly common. Available fixation options are not yet optimal. The PUMA System (Panther Orthopedics, Sunnyvale, CA) is an FDA-cleared superelastic, nitinol-based fixation device for the ankle syndesmosis which provides stabilization without over-compression or loosening during cyclical loading. The spring-like design of the PUMA System allows physiological micro-motion while maintaining continuous compression and resisting syndesmosis widening, without material creep. The objective of this prospective study is to assess the effectiveness and complication rate of the PUMA device for treatment of fracture-associated syndesmosis injuries. METHODS: We prospectively collected radiographic and clinical data on 32 consecutive patients treated for fracture-associated syndesmotic disruption with the PUMA System(TM) at 8 centers. Primary outcome measures included adverse event rates, radiographic evaluations for syndesmosis integrity and implant failure, and rates of revision surgery. RESULTS: All 32 patients had successful repair of their ankle syndesmosis (Figure 1). The mean age of patients at time of operation was 42 years (range 16- 68). There were 13 females (13/32, 40.6%) and 19 (19/32, 59.4%) males. Postoperative radiographic evaluations confirmed satisfactory syndesmosis healing with maintained reduction in the ankle mortise in 33/33 (100%) ankles. There was no evidence of lysis, device migration or syndesmotic or medial clear space widening. There were no infections or soft tissue complications. All fractures healed. No devices required removal and there were no revision surgeries. CONCLUSION: The PUMA System(TM) provides physiologic stabilization of the syndesmosis due to the design features that allow for continuous compression without creep. We found no device-related complications nor construct failures in our series. The superelastic implant design allows physiologic motion at the syndesmosis but does not creep or stretch following displacement. This flexibility obviates the need for routine removal. The implant's low-profile buttons without suture and knot tying requirements eliminate the concern for subcutaneous knot irritation and slippage. Additional biomechanical and clinical outcomes study of this device may further optimize rehabilitation protocols for patients treated for syndesmotic injury. SAGE Publications 2022-01-21 /pmc/articles/PMC8792651/ http://dx.doi.org/10.1177/2473011421S00187 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Article
Ellington, J. Kent
Hunt, Kenneth J.
Effectiveness of a Superelastic Nitinol Device for Fixation of Syndesmosis in Ankle Fracture
title Effectiveness of a Superelastic Nitinol Device for Fixation of Syndesmosis in Ankle Fracture
title_full Effectiveness of a Superelastic Nitinol Device for Fixation of Syndesmosis in Ankle Fracture
title_fullStr Effectiveness of a Superelastic Nitinol Device for Fixation of Syndesmosis in Ankle Fracture
title_full_unstemmed Effectiveness of a Superelastic Nitinol Device for Fixation of Syndesmosis in Ankle Fracture
title_short Effectiveness of a Superelastic Nitinol Device for Fixation of Syndesmosis in Ankle Fracture
title_sort effectiveness of a superelastic nitinol device for fixation of syndesmosis in ankle fracture
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792651/
http://dx.doi.org/10.1177/2473011421S00187
work_keys_str_mv AT ellingtonjkent effectivenessofasuperelasticnitinoldeviceforfixationofsyndesmosisinanklefracture
AT huntkennethj effectivenessofasuperelasticnitinoldeviceforfixationofsyndesmosisinanklefracture